ArticleFrontiers in neurology2025
Association between mean corpuscular volume and 3 month outcome in patients with acute ischemic stroke: a second analysis based on a prospective cohort study.
Article in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Pre-Thrombolysis Biological Correlates of Admission Glasgow Coma Scale in Older Adults with Acute Ischemic Stroke: A Retrospective Single-Center Cohort Study.Medicina (Kaunas, Lithuania) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Acute ischemic stroke is a major cause of global mortality and disability. This study aimed to investigate the association between mean corpuscular volume (MCV) and 3-month outcomes in acute ischemic stroke patients. Methods: This study is a secondary analysis based on a prospective cohort study conducted at a single center in Korea from January 2010 to December 2016. The study included 1,906 acute ischemic stroke patients. The exposure variable was MCV measured within 24 hours of admission, and the outcome variable was the modified Rankin Scale (mRS) score at 3 months post-admission. Covariates included age, gender, body mass index, hemoglobin, hematocrit, liver function indicators, diabetes history, and stroke etiology. Results: Piecewise linear regression analysis revealed a non-linear U‑shaped association of MCV on adverse outcomes, with a critical turning point at 92.1 fl. After full adjustment (Model 3), when MCV was below 92.1 fL, each 1 fL increase was associated with an 8% lower odds of poor 3-month outcome (OR = 0.92, 95% CI: 0.88-0.96, Conclusion: There was a U‑shaped association between MCV and three-month outcome in patients with acute ischemic stroke.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.